Bayer Sets Up $10 Billion Settlement Fund In Roundup-Cancer Claims

Bayer has agreed to pay more than $10 billion in the U.S. to settle current and potential claims that its Roundup herbicide causes cancer.

Bayer announced the settlement in a news release on Wednesday.

Bayer will set aside between $8.8 billion and $9.6 billion to resolve current Roundup litigation. The allocation will apply to 75% of the 125,000 current filed and unfiled claims that the product causes non-Hodgkin’s lymphoma.

The company also will cover potential future claims through a $1.25 billion allocation. That part of the settlement plan must be approved by Judge Vince Chhabria of the District Court for the Northern District of California.